Anti-CD20 antibody therapy can be effectively and safely administered subcutaneously to patients with MS, even when switching from a prior treatment, two clinical trials suggest.
People with multiple sclerosis and moderate-to-severe walking disability could engage in physical activity and improve their physical function with an adapted running frame, suggests new research.
People with multiple sclerosis and obesity can achieve substantial weight loss, leading to improved mobility and quality of life, with a specially designed program, new trial results suggest.
Clinicians prescribing a drug for patients with multiple sclerosis who are on multiple treatments may in future use AI to identify potential interactions and suggest safer options, new data suggest.